Union City, CA, United States of America

Ngon T Nguyen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ngon T Nguyen: Innovator in Gene Therapy

Introduction

Ngon T Nguyen is a prominent inventor based in Union City, CA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of recessive dystrophic epidermolysis bullosa. With a total of 3 patents, his work has the potential to transform the lives of individuals suffering from this debilitating condition.

Latest Patents

Ngon T Nguyen's latest patents focus on innovative methods for gene therapy. One of his notable patents involves the use of genetically corrected autologous keratinocytes for the treatment of recessive dystrophic epidermolysis bullosa. The methods provided facilitate cell-based delivery of collagen VII, which is crucial for treating epidermolysis bullosa and corneal erosion. Additionally, the patent discloses a composition that includes a keratinocyte sheet or a corneal cell sheet, further enhancing the therapeutic options available for patients.

Career Highlights

Throughout his career, Ngon T Nguyen has worked with esteemed institutions, including Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has allowed him to develop and refine his innovative approaches to gene therapy.

Collaborations

Ngon T Nguyen has collaborated with notable professionals in his field, including Zurab Siprashvili and M Peter Marinkovich. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Ngon T Nguyen is a dedicated inventor whose work in gene therapy is paving the way for new treatments for recessive dystrophic epidermolysis bullosa. His innovative patents and collaborations highlight his commitment to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…